IMRX Earnings

Quarterly EPS
$-0.49
Q3 2024
$-0.58
Q4 2024
$-0.42
Q1 2025
$-0.40
Q2 2025
$-0.38
Q3 2025
$-0.18
Q4 2025
$-0.21
Q1 2026
$-0.27
Q2 2026
Latest RevenueN/A
Latest Net Income-17270427
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.270-17270427+32.5%
Q1 2026-$0.210-13460895+50.0%
Q4 2025-$0.180-11580010+69.0%
Q3 2025-$0.380-14964875+22.4%
Q2 2025-$0.400-14433881+14.9%
Q1 2025-$0.420-15046132+14.3%
Q4 2024-$0.580-18051485-13.7%
Q3 2024-$0.490-14597366-14.0%
Q2 2024-$0.470-14079927
Q1 2024-$0.490-14307829
Q4 2023-$0.510-15083492
Q3 2023-$0.430-12595211
Immuneering (IMRX) — Earnings